Forte Biosciences Analyst Ratings
Chardan Capital Maintains Buy on Forte Biosciences, Maintains $3 Price Target
Forte Biosciences Analyst Ratings
Brookline Capital Initiates Coverage On Forte Biosciences With Buy Rating, Announces Price Target of $4
Ladenburg Thalmann: Upgraded Forte Biosciences (FBRX.US) rating from neutral to buy, with a target price of $2.75.
Forte Biosciences Analyst Ratings
No Data